Microglial release of IL-1β can also be driven by the neuropeptide substance P (SP), which is expressed in both microglia and glioma cells, along with its receptor NK-1 (Rasley et al., 2002; Watters et al., 2005; Cordier et al., 2014). This evidence concerns the gene IL1B and central nervous system cancer.